{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:08:27Z","timestamp":1747973307752,"version":"3.41.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,22]]},"DOI":"10.7759\/cureus.84600","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T09:41:16Z","timestamp":1747906876000},"source":"Crossref","is-referenced-by-count":0,"title":["Urosepsis From Nephrolithiasis Caused by Candida glabrata: A Rare Etiology of Urinary Sepsis in an Immunocompetent Patient"],"prefix":"10.7759","author":[{"given":"Jonathan","family":"Van Name","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krunal","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00288","article-title":"Urolithiasis is a risk factor for uroseptic shock and acute kidney injury in patients with urinary tract infection","volume":"6","author":"Hsiao CY","year":"2019","unstructured":"Hsiao CY, Chen TH, Lee YC, Hsiao MC, Hung PH, Chen YY, Wang MC. Urolithiasis is a risk factor for uroseptic shock and acute kidney injury in patients with urinary tract infection. Front Med (Lausanne). 2019, 6:288. 10.3389\/fmed.2019.00288","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles AL","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015, 13:269-84. 10.1038\/nrmicro3432","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2013.09.004","article-title":"Diagnosis and management of fungal urinary tract infection","volume":"28","author":"Kauffman CA","year":"2014","unstructured":"Kauffman CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin North Am. 2014, 28:61-74. 10.1016\/j.idc.2013.09.004","journal-title":"Infect Dis Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jof7080667","article-title":"Candida glabrata: Pathogenicity and resistance mechanisms for adaptation and survival","volume":"7","author":"Hassan Y","year":"2021","unstructured":"Hassan Y, Chew SY, Than LT. Candida glabrata: Pathogenicity and resistance mechanisms for adaptation and survival. J Fungi (Basel). 2021, 7:10.3390\/jof7080667","journal-title":"J Fungi (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1534\/g3.118.200182","article-title":"A host-pathogen interaction screen identifies ADA2 as a mediator of Candida glabrata defenses against reactive oxygen species","volume":"8","author":"Kounatidis I","year":"2018","unstructured":"Kounatidis I, Ames L, Mistry R, Ho HL, Haynes K, Ligoxygakis P. A host-pathogen interaction screen identifies ADA2 as a mediator of Candida glabrata defenses against reactive oxygen species. G3 (Bethesda). 2018, 8:1637-47. 10.1534\/g3.118.200182","journal-title":"G3 (Bethesda)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.1.80","article-title":"Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans","volume":"12","author":"Fidel PL Jr","year":"1999","unstructured":"Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999, 12:80-96. 10.1128\/CMR.12.1.80","journal-title":"Clin Microbiol Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas PG","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al.. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016, 62:e1-50. 10.1093\/cid\/civ933","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander BD","year":"2013","unstructured":"Alexander BD, Johnson MD, Pfeiffer CD, et al.. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013, 56:1724-32. 10.1093\/cid\/cit136","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/356466-urosepsis-from-nephrolithiasis-caused-by-candida-glabrata-a-rare-etiology-of-urinary-sepsis-in-an-immunocompetent-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T09:41:17Z","timestamp":1747906877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/356466-urosepsis-from-nephrolithiasis-caused-by-candida-glabrata-a-rare-etiology-of-urinary-sepsis-in-an-immunocompetent-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.84600","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}